A healthcare provider may prescribe Prolensa eye drops for use before cataract surgery. This medication is a type of nonsteroidal anti-inflammatory drug (NSAID), and it is used to reduce inflammation and pain. It is used the day before your surgery and used once a day for 14 days after surgery. Possible side effects may include eye pain and sensitivity to light.
What Is Prolensa?
Prolensa™ (bromfenac ophthalmic solution) is a prescription medication used to reduce inflammation and pain after cataract surgery. It belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs, or NSAIDs for short.
As mentioned previously, Prolensa belongs to a group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs work by blocking an enzyme known as cyclooxygenase (COX). The COX enzyme is responsible for the production of substances in the body known as prostaglandins.
Prostaglandins have a variety of functions in the body. One of their roles is to activate an inflammatory response, including inflammation in the eye, as well as cause pain. By blocking the production of prostaglandins, Prolensa reduces inflammation and pain.
Prolensa is given as an eye drop, and works directly in the eye. Very little, if any, of the drug is absorbed from the eye into the body with normal use.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed May 7, 2013.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click